COMPOSITION
Rabbit myxomatosis virus, strain “MAV/RK – 13/20” ≥ 104.0 TCID50 per dose.
PHARMACEUTICAL FORM
Lyophilisate, or lyophilisate and solvent.
IMMUNOBIOLOGICAL PROPERTIES
Post-vaccination protection in healthy rabbits appears on the 4th-9th day after vaccination and lasts for 8-10 months.
ANIMAL SPECIES
Rabbits.
INDICATIONS FOR USE
Used for the preventive vaccination of rabbits.
CONTRAINDICATIONS
Not to be used in weak, sick rabbits and those with acute and general febrile diseases.
CAUTIONS FOR USE
The vaccine must be used in accordance with aseptic rule
